Skip to content

You are reading 1 of 2 free-access articles allowed for 30 days

Irish researchers to lead €3 million study on new cystic fibrosis medication

Pictured are Annabel Murphy (aged 8) who has cystic fibrosis with Prof Paul McNally, RCSI Associate Professor of Paediatrics, at the launch of a new €3 million study, led by the RCSI, to investigate the real-world effects of a new cystic fibrosis medication. Researchers at the RCSI University of Medicine and Health Sciences are leading the international research project, called RECOVER, to look at how a new triple combination cystic fibrosis drug, Kaftrio, will affect people in their day-to-day lives. The project has been awarded €2.85 million from the Cystic Fibrosis Foundation (US), €112,000 from the Cystic Fibrosis Trust (UK), and €100,000 from Cystic Fibrosis Ireland.

Leave a Comment

You must be logged in to post a comment.

Scroll To Top